Table 1.
Grading of Recommendations, Assessment, Development and Evaluation (GRADE)
| Criteria | |
|---|---|
| Quality of evidence | |
| High (A) | Further research is unlikely to change confidence in the estimate of the clinical effect |
| Moderate (B) | Further research may change confidence in the estimate of the clinical effect |
| Low (C) | Further research is very likely to impact confidence on the estimate of clinical effect |
| Very low (D) | Any estimate of effect is uncertain |
| Strength of recommendation | |
| Strong (1) | Factors influencing the strength of the recommendation included the quality of the evidence, presumed patient important outcomes, and cost |
| Weak (2) | Variability in preferences and values, or more uncertainty. Recommendation is made with less certainty, higher cost or resource consumption |
Evidence level was graded down if there was only an abstract, poor quality or inconsistency between studies; level was graded up if there was a large effect size.